MedTrace Logo

Investigation of the iStent Inject® Devices in Open-Angle Glaucoma

NCT03624699 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 42

Last updated 2022-05-05

No results posted yet for this study

Summary

The aim of this study is to evaluate the safety and intraocular pressure (IOP) lowering effect of two iStent inject devices in combination with cataract surgery in patients with mild-to-moderate open-angle glaucoma.

Conditions

  • Glaucoma, Open-Angle

Interventions

DEVICE

Glaukos iStent inject®

iStent inject® Devices Implanted in Combination with Cataract Surgery in Patients with Open-Angle Glaucoma

Sponsors & Collaborators

  • Glaukos Corporation

    collaborator INDUSTRY

  • Dr. Kaweh Mansouri

    lead OTHER

Principal Investigators

  • Kaweh Mansouri, MD MPH · Glaucoma Research Centre, Montchoisi Clinic, Lausanne

  • André Mermoud, MD · Glaucoma Research Centre, Montchoisi Clinic, Lausanne

Study Design

Allocation
NA
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2018-04-25
Primary Completion
2019-12-31
Completion
2020-06-30
FDA Device
Yes

Countries

  • Switzerland

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03624699 on ClinicalTrials.gov